发现抗病毒药物的成功策略 1559条(本栏目收费,不能显示细节,电话15274084725)
ritonavir with CYP3A 461 461
binding pharmacophores 388 388
bioavailability 102,439,442 442
biologic RSV fusion inhibitors 31,35,38 38
bioterrorism 82,85,104 104
biotinylated NS5A HCV proteininhibitors 20,21 21
biphenyl moiety substitutions 11 11
bis(pivaloyloxymethyl) ester prodrug 429,430 430
BIT-225 (N-[5-(1-methyl-1H-pyrazol-4-yl)-naphthalene-2-carbonyl]-guanidine) 306,308,320,322,334,335,336 336
(2-[3-azaspiro(5,5)undecanol]-2-imidazoline) 305,317 317
black lipid membranes 300 300
BM2 protein of influenza B 318 318
BMS see Bristol,Meyers Squibb(BMS)boceprevir 190 190
Boehringer Ingelheim (BI)BI WO2005042530A1 RSV non-fusion inhibitor 49,50 50
tert-butoxy(4-phenylquinolin-3-yl)acetic acid NCINI derivatives 178,179 179
NS5B non-nucleoside inhibitors 251,252,253,254,255,263 263
boosted protease inhibitors 459 459
bovine viral diarrhea virus(BVDV) 6,7,298,306 306
bridge structures 11,12,261,263 263
Bristol,Meyers Squibb (BMS)6,9,22 22
3a CoV proteins 337,338 338
3M pharmaceuticals 369 369
6K alphavirus proteins 340 340
A1 finger loop residues 250,253,255,256 256
A-782759 alkoxyacetamide analogue 273 273
abacavir (ABC) 435,483,484,496,499 499